Contractor
SAGENT PHARMACEUTICALS, INC
- UEI
- PR1HCLM3FMW7
- Parent UEI
- YDRLCQE4AJE7
- Resolved by
- uei
- Confidence
- 1.000
Active from Mar 2, 2026 to May 4, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| SPE2D326F090J 4571706829!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | IL | May 4, 2026 | $24 |
| SPE2D326F059G 4571632359!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | IL | Apr 27, 2026 | $24 |
| SPE2D326F053N 4571593537!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | IL | Apr 23, 2026 | $96 |
| SPE2D326F050C 4571576404!LEVOFLOXACIN 750 MG/150 ML-D5W 150ML | Department of Defense | IL | Apr 22, 2026 | $46 |
| SPE2D326F9780 4571391075!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | IL | Apr 7, 2026 | $24 |
| SPE2D326F9704 4571389641!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | IL | Apr 7, 2026 | $24 |
| SPE2D326F9746 4571389643!PROPOFOL 1,000 MG/100 ML VIAL 100ML | Department of Defense | IL | Apr 7, 2026 | $60 |
| SPE2D326F9700 4571389644!METRONIDAZOLE 500 MG/100 ML 100ML | Department of Defense | IL | Apr 7, 2026 | $13 |
| SPE2D326F9595 4571378729!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | IL | Apr 6, 2026 | $24 |
| SPE2D326F9329 4571354173!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | IL | Apr 2, 2026 | $507 |
| SPE2D326F8562 4571263078!METRONIDAZOLE 500 MG/100 ML 100ML | Department of Defense | IL | Mar 25, 2026 | $52 |
| SPE2D326F8552 4571263079!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | IL | Mar 25, 2026 | $72 |
| SPE2D326F8508 4571269290!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | IL | Mar 25, 2026 | $24 |
| SPE2D326F7857 4571126390!METRONIDAZOLE 500 MG/100 ML 100ML | Department of Defense | IL | Mar 12, 2026 | $13 |
| SPE2D326F7851 4571126389!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | IL | Mar 12, 2026 | $24 |
| SPE2D021D0003 4610071705! | Department of Defense | — | Mar 11, 2026 | — |
| SPE2D326F7044 4571016155!METRONIDAZOLE 500 MG/100 ML 100ML | Department of Defense | IL | Mar 3, 2026 | $13 |
| SPE2D326F7042 4571016156!METRONIDAZOLE 500 MG/100 ML 100ML | Department of Defense | IL | Mar 3, 2026 | $13 |
| SPE2D326F6860 4570999152!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | IL | Mar 2, 2026 | $193 |
| SPE2D326F6830 4571002349!GLYDO 2% JELLY SYRINGE 11ML | Department of Defense | IL | Mar 2, 2026 | $39 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier PR1HCLM3FMW7, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 28, 2026.